Hot Topics: Genomics, Imaging and AI in Management of Localized Prostate Cancer

Thursday, October 30, 2025

14:00 - 15:30 GMT+0

Co-Chair(s)

Magdalena Goertz

Senior urological surgeon, Research group leader
University Hospital Heidelberg, Germany; German Cancer Research Center, Germany
Laurence Klotz

Professor of Surgery
Sunnybrook Research Institute, Canada

At the end of this session, attendees should be able to:

Evaluate the role of genomic classifiers for personalized risk assessment and treatment decision-making in localized prostate cancer.
Assess the impact of advanced imaging modalities, such as MRI and PSMA PET, on active surveillance and staging.
Discuss the indications, outcomes, and limitations of radical prostatectomy and radiation therapy for localized prostate cancer.
Examine the integration of molecular markers and artificial intelligence in clinical decision-making.

14:00 - 14:12 GMT+0

Genomics in risk classification
Speaker: Magdalena Goertz – University Hospital Heidelberg, Germany; German Cancer Research Center
14:12 - 14:24 GMT+0

MRI Enabled AS
Speaker: Caroline Moore – University College London
14:24 - 14:36 GMT+0

Surgery vs Radiation
14:36 - 14:48 GMT+0

PSMA PET for localised disease
Speaker: Peter Chiu – The Chinese University of Hong Kong
14:48 - 15:00 GMT+0

Molecular Markers & PSMA Expression
Speaker: Robert Reiter – University of california Los Angeles
15:00 - 15:12 GMT+0

AI in Decision-making
15:12 - 15:30 GMT+0

Discussion and Concluding Remarks